Turkish Validation of the Geriatric Pain Measure - Short Form

March 18, 2025 updated by: Tuba Tanyel Saraçoğlu, Başakşehir Çam & Sakura City Hospital

Turkish Adaptation, Validation, and Reliability Assessment of the Geriatric Pain Measure - Short Form

This study aims to adapt, validate, and assess the reliability of the Geriatric Pain Measure - Short Form in Turkish. A total of 150 patients aged 65 years and older will complete the scale under the supervision of pain management and gerontology specialists. Reliability and validity will be evaluated using statistical analyses, including internal consistency, test-retest reliability, and correlation with validated pain and sleep scales. Ethical approval has been obtained, and all participants will provide informed consent.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

For the Turkish adaptation, validation, and reliability study of the Geriatric Pain Measure - Short Form, permission was obtained from Dr. Eva Blozik, the original developer of the scale. The adaptation process will follow standard cross-cultural validation guidelines, including forward translation into Turkish by an expert group, back-translation into English by a separate expert group, and comparison of the back-translated version with the original English version for conceptual and linguistic accuracy. A multidisciplinary expert panel, including Turkish language specialists and pain management experts, will review the final Turkish version, making necessary cultural adaptations to ensure semantic equivalence. The study will involve 150 patients aged 65 years and older visiting the Pain Management Clinic, where they will complete the Turkish version of the scale under the supervision of pain management and gerontology specialists. Reliability will be assessed through internal consistency (Cronbach's alpha), test-retest reliability, and item-total correlations, while construct validity will be evaluated using factor analysis. Concurrent validity will be examined by correlating the Turkish version of the scale with other outcome measures. Ethical approval has been obtained from Başakşehir Çam and Sakura City Hospital Ethics Committee, and all participants will provide written informed consent before participation.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey
    • Başakşehir
      • İstanbul, Başakşehir, Turkey
        • Recruiting
        • Başakşehir Çam and Sakura City Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients over 65 years of age who applied to the pain management outpatient clinic with the complaint of chronic pain and consented to participate the study.

Description

Inclusion Criteria:

  • Geriatric patients with chronic pain
  • Patients who agreed to participate in the study

Exclusion Criteria:

  • Demantia
  • Mental of physical disorders that effect patients answering the scales
  • Diagnosis of malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Geriatric Patients with Chronic Pain
Geriatric patients (≥65 years) with chronic pain who are examined at the Pain Management Clinic of Başakşehir Çam and Sakura City Hospital. Participants will be assessed under the supervision of pain management and gerontology specialists.
Other: Geriatric Pain Measurement Short Form
Geriatric Pain Measure - Short Form (GPM-SF) is a validated pain assessment tool designed specifically for older adults. It is a 12-item questionnaire that evaluates pain intensity, interference with daily activities, and emotional impact of chronic pain in geriatric patients. The short form provides a quick and reliable assessment of pain-related disability in older populations.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Geriatric Pain Measurement Short Form
Time Frame: Day 1
Geriatric Pain Measure - Short Form (GPM-SF) is a validated pain assessment tool designed specifically for older adults. It is a 12-item questionnaire that evaluates pain intensity, interference with daily activities, and emotional impact of chronic pain in geriatric patients. The short form provides a quick and reliable assessment of pain-related disability in older populations.
Day 1
Numerik Rating Scale
Time Frame: Day 1
The Numeric Rating Scale (NRS) is a 0 to 10 scale used to assess pain intensity, where 0 = no pain and 10 = worst possible pain. It is a simple, reliable tool widely used in clinical and research settings.
Day 1
FRAIL Scale
Time Frame: Day 1
The FRAIL Scale is a five-item questionnaire used to assess frailty in older adults. It evaluates Fatigue, Resistance (weakness), Ambulation (mobility), Illnesses (comorbidities), and Loss of weight. A higher score indicates a greater degree of frailty, helping identify patients at risk for adverse health outcomes.
Day 1
Lawton & Brody Instrumental Activities of Daily Living Scale
Time Frame: Day 1
The Lawton & Brody Instrumental Activities of Daily Living, a scale that assesses an older adult's ability to perform eight complex daily tasks essential for independent living. These tasks include using the telephone, shopping, meal preparation, housekeeping, laundry, transportation, medication management, and handling finances. It helps evaluate functional independence and detect early declines in cognitive or physical abilities
Day 1
Geriatric Depression Scale-15
Time Frame: Day 1
The Geriatric Depression Scale-15 (GDS-15) is a shortened version of the original GDS, consisting of 15 yes/no questions designed to screen for depression in older adults. It is simple, quick, and reliable, making it suitable for use in clinical and research settings, including in patients with mild cognitive impairment. Higher scores indicate more depressive symptoms.
Day 1
Pittsburgh Sleep Quality Index
Time Frame: Day 1
The Pittsburgh Sleep Quality Index is a self-reported questionnaire assessing sleep quality over the past month. It includes 18 items evaluating aspects such as sleep duration, latency, disturbances, efficiency, daytime dysfunction, and use of sleep medications. A higher total score indicates poorer sleep quality
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Başakşehir Çam & Sakura City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 15, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 15, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 15, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 10, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 10, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 18, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 26.02.2025.73

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings